Answers are grounded in this paper and cite their sources.
The efficient detection of tumor markers is crucial to early cancer diagnosis and monitoring. Here, we propose a unique “two birds with one stone” dissolution-enhanced afterglow bioassay based on amino-functionalized mesoporous SiO 2 nanoparticles (MSNs-NH 2 ) encapsulated Eu(OH)CO 3 nanoprobes. These nanoprobes (i) stably conjugate to the antibody and (ii) are highly soluble in the acidic enhancer solution, and provide a high Eu 3+ concentration. The released Eu 3+ ions further activate the photochemical afterglow system to determine the alpha-fetoprotein (AFP) levels in clinical serum samples. Without the use of a real-time excitation source, the interference of autofluorescence and scattering from blood can be avoided. The demonstrated limit of detection (LOD) for AFP was as low as 0.12 ng·mL −1 . This covalently connected dissolution-enhanced luminescent bioassay (DELBA) and novel afterglow system shows tremendous potential for ultrasensitive and rapid clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: